SDC1 and neoplasm: As tumor accumulation is mostly due to the passive targeting of the EPR effect, this large decreased accumulation is likely due to off-target binding of the CD138-targeted nanoparticles to other nontumor cells, caused by their particularly high avidity that was observed in vitro.